Research News and Research

RSS

Research confirms benefits of commonly used traditional remedies for a range of illnesses

Research presented to the British Pharmaceutical Conference today, confirms the benefits of commonly used traditional remedies for a range of illnesses, including cancer, offering a scientific justification for their use.

29 Sep 2004

New funding for Scottish scientists to tackle diseases such as asthma and multiple sclerosis

Scientists at the University of Aberdeen have been awarded £196,166 to help fund pioneering research, which is exploring a method of combating certain conditions and diseases such as asthma and multiple sclerosis.

29 Sep 2004

Draft Medicare plan to cover implantable defibrillators

The Centers for Medicare & Medicaid Services (CMS) today proposed to expand coverage of implantable cardioverter defibrillators (ICDs), a move expected to save thousands of lives a year.

29 Sep 2004

IT for patient care varies widely across U.S. physician practices

While there's wide enthusiasm for harnessing the power of information technology (IT) to improve U.S. medical care, fewer than a quarter of physicians in 2001 could generate electronic treatment reminders for use during patient visits and only about 10 percent could write electronic prescriptions

29 Sep 2004

Charles Darwin University is responding to claims that Australians are now among the fattest people on earth

Australia's Charles Darwin University is responding to claims that Australians are now among the fattest people on earth with a health program targeting childhood obesity.

29 Sep 2004

Brand-conscious customers necessitate robust supply chain management in custom procedure tray markets

End users such as surgeons and operating room (OR) staff are very brand conscious, and the inability of custom procedure tray (CPT) vendors to provide a desired brand may result in loss of business and inability to maintain healthy customer relations.

29 Sep 2004

Cancer Research Technology and The Institute of Cancer Research complete licence with Vernalis

Cancer Research Technology Limited (CRT) and The Institute of Cancer Research announce that Vernalis plc has licensed exclusive worldwide rights to an anti-cancer Hsp90 inhibitor programme.

29 Sep 2004

On-line campaign asks, where does all the breast cancer research money go?

Barbara Ehrenreich and Breast Cancer Action (BCA) have launched an online Flash movie and email campaign that exposes the lack of coordination among more than 30 federal agencies and dozens of private foundations and pharmaceutical companies funding research on breast cancer.

28 Sep 2004

Should medical knowledge be extended to enhance the lives of those who are already healthy?

This question and others are addressed in three articles about cosmetic neurology in the September 28 issue of Neurology, the scientific journal of the American Academy of Neurology.

28 Sep 2004

Clusters of genes within human aortas appear to predict risk for atherosclerosis

Duke University Medical Center researchers have identified specific clusters of genes within human aortas that appear to predict with great specificity which patients may be at highest risk for developing atherosclerosis, as well as the severity of the disease.

28 Sep 2004

Guideline evaluates treatments for postherpetic neuralgia

A new guideline from the American Academy of Neurology evaluates treatments for postherpetic neuralgia. The guideline is published in the September 28 issue of Neurology, the scientific journal of the American Academy of Neurology.

28 Sep 2004

Phase II trials of the first second-generation antisense cancer drug to be used in patients soon to be underway

Phase II trials of the first second-generation antisense cancer drug to be used in patients are soon to be underway in the wake of a successful Phase I study, which has demonstrated that the new drug blocks its target gene in exactly the way it is designed to do.

28 Sep 2004

Trial shows which brain cancer patients benefit from temozolomide

An international team of scientists and cancer specialists has identified which patients with the deadly form of brain tumours called glioblastomas are likely to live longer if they are treated with temozolomide, and which patients are likely to get only marginal, if any, benefit.

28 Sep 2004

Researchers reveal potential new role for Glivec/Imatinib

Imatinib – or Glivec as it also known – looks as if it may become an effective treatment for yet another type of cancer.

28 Sep 2004

Arsenic trioxide - invented as a treatment for a rare type of leukaemia

Arsenic trioxide – a highly poisonous substance best known as an effective weed killer or pesticide and notorious for being a favourite ‘weapon’ of choice in murder mystery novels, is being re-invented as a treatment for a rare type of leukaemia.

28 Sep 2004

Microfluidics help lab-on-a-chip development skyrocket

Lab-on-a-chip (LOC) development has skyrocketed in the last couple of years due to constant efforts in harnessing microfluidics and µTAS to improve the LOC design and function. The distinct advantages that they bestow on applications are pushing the commercial potential of LOCs.

28 Sep 2004

Master gene that controls the first breath a newborn infant

Researchers at Cincinnati Children's Hospital Medical Center have identified a master gene that controls the first breath a newborn infant takes. The findings could have implications for treating premature babies and children and adults with lung disease or lung injury.

28 Sep 2004